General and Administrative Expense of Akari Therapeutics Plc from 28 Feb 2014 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Akari Therapeutics Plc quarterly and annual General and Administrative Expense in USD history and change rate from 28 Feb 2014 to 30 Jun 2024.
  • Akari Therapeutics Plc General and Administrative Expense for the quarter ending 30 Jun 2024 was $1,281,985, a 44% decline year-over-year.
  • Akari Therapeutics Plc annual General and Administrative Expense for 2023 was $8,292,072, a 2.8% decline from 2022.
Source SEC data
View on sec.gov
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)

Akari Therapeutics Plc Quarterly General and Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,281,985 -$1,017,073 -44% 01 Apr 2024 30 Jun 2024 8-K 06 Sep 2024
Q2 2023 $2,299,058 01 Apr 2023 30 Jun 2023 8-K 06 Sep 2024
Q1 2014 $56,000 01 Feb 2014 28 Feb 2014 10-Q 12 Aug 2015 2015 Q2

Akari Therapeutics Plc Annual General and Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $8,292,072 -$239,204 -2.8% 01 Jan 2023 31 Dec 2023 8-K 06 Sep 2024
2022 $8,531,276 01 Jan 2022 31 Dec 2022 8-K 06 Sep 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.